Esperion Therapeutics, Inc. SEC filings

Filings

1. SCHEDULE 13GEsperion Therapeutics, Inc.ESPRAug 13

   Ownership stake disclosure by GOLDMAN SACHS GROUP INC

   GOLDMAN SACHS GROUP INC, filed by

2. SCHEDULE 13GEsperion Therapeutics, Inc.ESPRJul 31

   Ownership stake disclosure by VANGUARD CAPITAL MANAGEMENT LLC

   VANGUARD CAPITAL MANAGEMENT LLC, filed by

3. 15-12GEsperion Therapeutics, Inc.ESPRJul 23

   Deregistration notice

4. EFFECTEsperion Therapeutics, Inc.ESPRJul 16

   Registration declared effective

5. EFFECTEsperion Therapeutics, Inc.ESPRJul 16

   Registration declared effective

6. EFFECTEsperion Therapeutics, Inc.ESPRJul 16

   Registration declared effective

7. EFFECTEsperion Therapeutics, Inc.ESPRJul 16

   Registration declared effective

8. EFFECTEsperion Therapeutics, Inc.ESPRJul 16

   Registration declared effective

9. EFFECTEsperion Therapeutics, Inc.ESPRJul 16

   Registration declared effective

10. SCHEDULE 13G/AEsperion Therapeutics, Inc.ESPRJul 14

    Ownership stake disclosure by WASATCH ADVISORS LP (amended)

    WASATCH ADVISORS LP, filed by

11. 4Esperion Therapeutics, Inc.ESPRJul 13

    9 insider filings

    Robert E. Hoffman, insider filing for ESPR

    Show all 9

    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13
    • 4Insider filing for ESPRJul 13

    Robert E. Hoffman, reporting

12. POSASREsperion Therapeutics, Inc.ESPRJul 13

    POSASR filing

13. POS AMEsperion Therapeutics, Inc.ESPRJul 13

    POS AM filing

14. POS AMEsperion Therapeutics, Inc.ESPRJul 13

    POS AM filing

15. POS462BEsperion Therapeutics, Inc.ESPRJul 13

    POS462B filing

16. POS AMEsperion Therapeutics, Inc.ESPRJul 13

    POS AM filing

17. POS AMEsperion Therapeutics, Inc.ESPRJul 13

    POS AM filing

18. POS AMEsperion Therapeutics, Inc.ESPRJul 13

    POS AM filing

19. POS AMEsperion Therapeutics, Inc.ESPRJul 13

    POS AM filing

20. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

21. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

22. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

23. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

24. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

25. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

26. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

27. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

28. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

29. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

30. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

31. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

32. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

33. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

34. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

35. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

36. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

37. S-8 POSEsperion Therapeutics, Inc.ESPRJul 13

    S-8 POS filing

38. 25-NSEEsperion Therapeutics, Inc.ESPRJul 13

    Delisting notice

    Nasdaq Stock Market LLC, filed by

39. 8-KEsperion Therapeutics, Inc.ESPRJul 13

    Current report

40. 8-KEsperion Therapeutics, Inc.ESPRJul 8

    Current report

41. 4Esperion Therapeutics, Inc.ESPRJun 18

    2 insider filings

    Benjamin Halladay, insider filing for ESPR

    Show all 2

    • 4Insider filing for ESPRJun 18
    • 4Insider filing for ESPRJun 18

    Benjamin Halladay, reporting

Older filings on EDGAR